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1 Introduction 
 
1.1 History and Epidemiology of Sepsis 
 
Sepsis is a term describing a clinical condition in which a known or suspected 
pathogenic organism causes a potentially deadly whole body inflammation (Bone et al., 
1992; Levy et al., 2003). It is also referred as “septicemia” or “blood poisoning”. A septic 
patient usually has a focus of infection which spreads so rapidly that the body’s own 
defense mechanisms cannot contain its progression to the whole body. A sepsis is 
frequently associated with several of the following unspecific symptoms: hyper- or 
hypothermia, leukocytosis or leucopenia, tachycardia and tachypnea.  
While sepsis represents a major challenge in modern intensive medicine, it has been 
described often since ancient times. The renowned Greek physician Hippocrates (ca. 
460 - 370 BC) already described sepsis with the Greek word σηπω (pronounced “sipsi”) 
which means to "make rotten" (Kreymann, 1996). Ibn Sina (979-1037), an antique 
Persian physician, referred to sepsis as a sickness of the blood causing fever (Rittirsch 
et al., 2008). This rather vague concept was widely accepted in the western medicine 
until Ignaz Semmelweis (1818-1865) developed what was close to the modern view of 
sepsis. Semmelweis, an obstetrician at the Vienna General Hospital, observed that the 
high mortality rate of 18% at his department correlated to the frequency of pelvic 
examination on his patients performed by the medical students. These students 
examined the female patients directly after their pathology lessons without cleaning their 
hands. He concluded that the students must have caught "a decomposed animal matter 
that entered the blood system" which caused the deadly septic conditions in the patients 
(Semmelweis, 1861). He then introduced hand washing with a chlorinated lime solution 
before every gynecological examination and was able to reduce the mortality rate to 
about 2.5%. Semmelweis’ observation shed some light on the understanding of septic 
infection. Furthermore, the discovery of bacteria by Louis Pasteur in 1857 helped 
scientists to understand the nature of an infection caused by bacterial pathogens 
(Pasteur, 1857). It was, however, not until the mass production of Penicillin after World 
War II that mankind could begin to fight against bacterial infection actively (Conly et al., 
2005). 
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For the optimization of therapy strategies, a systematic understanding and a reliable 
classification of sepsis, a consensus conference between the American College of Chest 
Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) was held in 
Chicago, IL in August, 1991 (ACCP/SCCM Consensus Conference Committee, 1992). 
There, a modern definition of sepsis and the guidelines for the use of innovative 
therapies in sepsis were developed for the purpose of “improving our ability to make 
early bedside detection of the disease possible, and thus allowing early therapeutic 
intervention” (Bone, 1992). The conference coined the term SIRS (Systemic 
Inflammatory Response Syndrome) and categorized sepsis into four levels (See Table 
1). 
 
Tab. 1: Definition of SIRS and sepsis (ACCP/SCCM-criteria) 
SIRS 
(Systemic 
Inflammatory 
Response 
Syndrome) 
Two or more of the following criteria 
(1) temperature >38°C or <36°C 
(2) heart rate >90 beats per minute 
(3) respiratory rate >20 breaths per minute or PaCO2, <32 mm Hg 
(4) white blood cell count >12,000 cells/μl, <4,000 cells/μl, or 
>10% immature (band) forms 
Sepsis Documented infection together with two or more SIRS criteria 
Severe Sepsis 
Sepsis associated with organ dysfunction, including, but not 
limited to, lactic acidosis, oliguria, hypoxemia, coagulation 
disorder, or an acute alteration in mental status. 
Septic Shock 
Sepsis with hypotension, despite adequate fluid resuscitation, 
along with the presence of perfusion abnormalities. Patients who 
are on inotropic or vasopressor agents may not be hypotensive at 
the time when perfusion abnormalities are detected. 
 
In this classification, sepsis is differentiated from SIRS by the presence of a documented 
pathogen. For example, SIRS and a positive blood culture for a pathogen indicate the 
presence of a sepsis. In practice, however, in only about half of the suspected sepsis 
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cases the presence of a pathogen is actually verified through blood culture (Jones et al., 
1996). 
Today, there are at least 14 widely used types of antibacterial agents for humans by 
which a sepsis may be treated (Conly et al., 2005). Possibilities of device support for 
critical hemodynamic conditions in septic patients have been improving rapidly as well. 
Still, sepsis remains to be a major medical problem. In the United States sepsis is the 
second leading cause of death among non-cardiac Intensive Care Unit (ICU) patients, 
and the tenth most common cause of death overall, according to data from the Centers 
for Disease Control and Prevention (CDC, Martin et al., 2003). Sepsis is common and 
more hazardous for elderly, immune compromised and critically ill patients (Bone, 1992; 
Cohen, 2009). It occurs in 1–2% of all hospitalizations and accounts for as much as 25% 
of ICU bed utilization. The mortality rates range from 20% for sepsis, 40% for severe 
sepsis, to over 60% for septic shock. 
 
1.2 The Structure and the Function of the Cardiomyocyte 
 
In observing the pathophysiological mechanism of a septic shock in an isolated 
cardiomyocyte, it is essential to have a clear understanding of the structure and the 
function of a cardiomyocyte. The cardiomyocyte belongs to the group of striated muscle 
cells that are connected together to form the myocardial tissue. Cardiomyocytes are 
about 50-100 μm in length and have a single centrally positioned nucleus. Each cell is 
connected to one another in a branched manner through specialized sites known as 
intercalated discs (Franke et al., 2006). Two structures that are found within the 
intercalated discs are desmosomes and gap junctions. Desmosomes are specialized 
structures involved in cell-to-cell adhesion and gap junctions are intercellular channels 
that connect the cytoplasm of adjacent cells, allowing the free passage of molecules, 
ions and electrical signals. The most conspicuous structures in the cytoplasm of a 
cardiomyocyte are the myofibrils which enable the shortening of the cells. The myofibrils 
are responsible for the cross-striated appearance of the cardiomyocytes. Myofibrils are 
composed of sarcomeres which are the smallest contractile unit. Sarcomere length is 
around 1.8 µm at rest (Craig et al., 2014). An increase of the cytoplasmic calcium ion 
concentration, [Ca2+]i, causes a shortening of the sarcomere, leading to myocardial 
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contraction. On the other hand, a decrease in [Ca2+]i induces relaxation of the 
myofilaments. 
Electrical stimuli, called action potentials, AP, are required for cardiomyocyte contraction. 
The cardiac AP is initiated by a pacemaker located in the sinus node. The cardiac AP 
propagates across cardiomyocytes through gap junctions, allowing the cells to contract 
in a synchronized fashion, which enables the heart to contract as one muscle and thus 
to pump the blood in a coordinated manner (Craig et al., 2014). 
An AP will depolarize the membrane potential and initiate a calcium inward current. This 
calcium inward current initiates a calcium release from the sarcoplasmic reticulum, 
which acts as the intracellular calcium store. As mentioned above, the increase in [Ca2+]i 
i initiates shortening and a decrease in [Ca2+]i leads to relaxation of the sarcomeres. This 
mechanism of the myocardial contraction can be influenced by changing of outer 
conditions. This study will observe the effect of a bacterial sepsis on an isolated 
cardiomyocyte. It is well known (Kohl et al., 2005) that isolated cardiomyocytes can be 
used as model for cardiac excitation contraction coupling. Experiments on single cell 
level have the advantage to reduce the amount of influencing factors compared to in 
vivo conditions and thus allow to establish simple cause-effect relations. Therefore, 
single cell experiments on isolated cardiomyocytes were performed in this study. 
 
1.3 Pathogenesis of the Reduction of Myocardial Contractility 
 
As mentioned in Chapter 1.2, sepsis is a major medical problem which is associated 
with high mortality rate. The main contributor to sepsis related morbidity and mortality is 
cardiac dysfunction, also called septic cardiomyopathy, causing systolic and diastolic 
dysfunction in both ventricles due to preload and afterload decrease (Muller-Werdan et 
al., 2006, Parrillo et al., 1990). On cellular level, the contractility of the cardiomyocytes is 
reduced so that the function of the heart as a pumping organ is compromised as a whole. 
A systematic vasodilatation leading to a refractory hypotension is characteristic in septic 
patients as well. It brings the myocardial oxygen supply demand ratio out of balance. 
This vicious circle continues until the rest of the body suffers from a systematic ischemia 
and multi organ dysfunction, which leads to death of the patient. About 20% of all septic 
patients with refractory hypotension die because of a low cardiac output under septic 
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cardiomyopathy (Fernandes et al., 2008). The treatment of septic patients without further 
compromising the already reduced function of the septic heart is, therefore, of high 
clinical relevance. 
Although the pathophysiology of the septic cardiomyopathy is not fully understood, 
recent findings suggest that the innate immune defense plays an important role. The 
acquired immune defense system, led by B and T lymphocytes, is highly differentiated 
and can bind antigens specifically. The recognition of the pathogen and the production 
of adequate antibody through plasma cells, however, often take three to five days which 
is enough time for microorganisms to cause a fulminant sepsis. On the other hand, the 
innate immune defense system is less specific with only about some hundred different 
receptors. It can readily bind structures that are relatively uninfluenced by genetic 
variability, thus exhibiting patterns that are conserved and rarely change. These antigen 
structures are called pathogen-associated-molecular-patterns (PAMPs) (Medzhitov et al., 
2000). PAMPs can be described as small molecular motifs conserved within a class of 
microbes. They are recognized by Toll-like receptors (TLRs) and other pattern 
recognition receptors (PRRs) in animals and plants. They activate an innate immune 
response, protecting the host from infection by foreign material. Common PAMPs 
include lipopolysaccharide (LPS, recognized by TLR4), bacterial flagellin (recognized by 
TLR5), lipoteichoic acid from Gram positive bacteria, peptidoglycan, and nucleic acid 
variants normally associated with viruses, such as double-stranded RNA (dsRNA, 
recognized by TLR3) and unmethylated CpG (Cytosin-Phosphate-Guanosin) motifs, 
abundant in microbial genomes (recognized by TLR9). 
Bacterial lipopolysaccharide, an endotoxin found in the bacterial cell membrane, is 
considered to be the prototypical PAMP. It is the major component of the outer 
membrane of gram-negative bacteria, contributing to the structural integrity of the 
bacterium and protecting the membrane from the outer influence (Medzhitov, 2001; 
Pålsson-McDermott and O’Neill, 2004). 30% to 50% of all reported sepsis cases involve 
an infection with gram-negative bacteria which makes LPS clinically highly relevant as a 
PAMP (Rensing, 2003). Common gram-negative bacteria, which play important roles in 
modern medicine, are, for example, Escherichia coli, Salmonella, Shigella, 
Pseudomonas, Helicobacter, Legionella, Neisseria, Hemophilus, and Klebsiella. LPS, as 
described, acts as the prototypical endotoxin because it binds the CD14/TLR4/MD2 
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receptor complex, which promotes the secretion of proinflammatory cytokines in many 
cell types including cardiomyocytes, macrophages and B cells. (See Figure 1) LPS 
consists of a polysaccharide and a phospholipid section. (See Figure 2) The 
polysaccharide section, also called O antigen, has up to 50 repeating carbohydrate 
chains and can be used for serotyping of the bacterium. The rest can be categorized into 
the outer core, the inner core, and the phospholipid section (Lipid A). The Lipid A section 
(See Figure 2) is mainly responsible for the immune stimulating toxicity of LPS 
(Alexander and Rietschel, 2001; Lien et al., 2000; Medzhitov, 2001; Rensing, 2003; 
Schletter et al., 1995).  
LPS is connected to the outer membrane of a bacterium through its Lipid A section and 
makes up about 75% of the outer layer of gram-negative bacteria (Alexander and 
Rietschel, 2001). If a bacterium breaks down due to the effect of antibiotics or lysis by 
the immune system, LPS is released. This is recognized by TLR4 (Medzhitov, 2001; 
Mukhopadhyay et al., 2004; Pålsson-McDermott and O’Neill, 2004). TLR4 consists of an 
extracellular leucine abundant region and an intracellular Toll/IL-1-Domain (TIR). 
 
Fig. 1: Schematic Signal Cascade of LPS binding 
the CD14/TLR4/MD2 Complex (Buer and Balling, 
2003) 
 
 
 
 
 
 
 
 
 
 
The transmembraneous structure allows to transduct signals from the outside to the 
inside of a cell (Lakhani and Bogue, 2003; Medzhitov, 2001). The first structure that 
binds LPS is LPS-binding protein (LBP) which is secreted in the liver and circulates 
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freely in blood. Serum LBP binds the Lipid A section with high affinity and brings it to the 
CD14 molecule which is located on the cell surface (Schumann et al., 1990). After the 
combination of these three components (LPS, LBP, CD14), LPS can be loaded onto the 
receptor complex, which is composed of a TLR4 receptor and the extracellular adapter 
MD2 (Nagai et al., 2002, Schromm et al., 2001). MD2 is a glycoprotein that connects two 
TLR4 molecules on the extracellular side, and is an essential factor in the LPS signaling 
pathway. 
Unlike CD14, MD2 binds TLR4 directly, although the presence of CD14 is needed to 
initiate the signal transduction of TLR4 in many cases, as Visintin et al. (2002) 
demonstrated. Namely, they showed a reduced responsiveness to LPS. On the contrary, 
mice with overexpression of CD14 showed more intensive inflammatory reactions 
(Ferrero et al., 1993). Still the fact that LPS induced some significant, though reduced, 
reactions in CD14 deficient mice suggested that there is a signaling pathway which does 
not involve CD14 and this could be demonstrated later (Godowski et al., 2005; Haziot et 
al. 1998; Jiang et al., 2005). 
Through the binding of LPS to the TLR4 receptor complex, a signal pathway begins 
which then activates the transcription factor NFκB that increases the transcription of 
proinflammatory cytokines, such as TNFα, IL-1β, IL6, and IFNγ. 
 
Fig. 2: The structure of E. coli LPS (Ruiz et al., 2009) 
LPS consists of a core section and a lipid A section. 
The Lipid A section is responsible for the toxicity of 
LPS. 
 
 
 
 
 
 
 
 
 
  
 
 
17 
In addition, the expression of the inducible NO-Synthase (iNOS) is increased. The 
expression and the secretion of these cytokines result in the reduction of contractility of 
the heart muscle, as clinically and experimentally demonstrated (Avlas et al., 2011; 
Baumgarten et al., 2006; Boyd et al., 2006; Kapadia et al., 1995; Muller-Werdan et al., 
2006; Pagani et al., 1992). Baumgarten et al. furthermore demonstrated that isolated 
heart muscle cells treated with LPS showed reduced contractility with lower sarcomere 
shortening amplitude and prolonged duration of relaxation. 
 
1.4 Objective of this Study 
 
In this study the effect of bacterial sepsis caused by LPS should be observed on the 
cellular level. Murine cardiomyocytes should be isolated and incubated with or without 
LPS, thus simulating a septic shock. The hypothesis of this study was that LPS will 
reduce shortening of isolated cardiomyocytes and that this can be overcome by β-
stimulation. This hypothesis should be tested quantitatively on single cell level. 
Therefore, isolated cardiomyocytes should be incubated in LPS and then stimulated by 
orciprenaline. Comparison of septic cardiomyocytes with and without β-stimulation 
should reveal the potency of β-stimulation on LPS treated cells. 
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2 Material and Methods 
 
2.1 Test Animals and Maintenance Conditions 
 
Male C57BL/6 mice were obtained from Charles River Deutschland GmbH (Sulzfeld, 
Germany). The mice were raised and maintained in full accordance to the current 
guidelines for use and care of laboratory animals. The animals were kept in cages made 
of polycarbonate, each measuring 365 x 207 x 140mm in size. The bottom was covered 
by Altromin Animal Hay Granulate (Altromin GmbH und Co. KG, Lage-Lippe, Germany). 
A constant living environment (temperature between 20C and 22C, relative air 
humidity at 50%, twelve hours shifting day and night circadian rhythm) was provided 
consistently for the mice. The cages were mounted in a mouse cage shelving system. 
Each cage could be pulled out of the shelf and attended separately. Separated 
ventilation for each cage was provided in order to guarantee optimal hygienic conditions. 
The animals were fed with clean tab water and a standard diet (Altromin for mice and 
rats). The amount was not limited. The young animals at the mentioned inbreeding 
facility were separated from their parent animals at the age of four weeks and were 
sorted and separated by gender. 
 
2.2 Description of the Experimental Method and Cell Groups 
 
Ventricular cardiomyocytes were isolated freshly from murine hearts for each in vitro 
experiment. The main objective was the precise measurement of the extent of 
sarcomere shortening under control conditions and under the influences of various 
stimulating factors which are to be introduced later in detail. 
Isolated cardiomyocytes were divided into three groups. The control measuring of 
sarcomere was done with the newly isolated cells that were suspended in a Tyrode’s 
solution (See Table 2.1). The remainder of the cells was incubated in culture mediums, 
separated in two groups, for 6 hours after which the experiment was performed. The 
cells of the first group were initially stimulated with LPS and were incubated in order to 
simulate a septic condition. The second group was incubated without an addition of a 
stimulant. 
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2.2.1 Isolation of Ventricular Cardiomyocytes 
 
The isolation of ventricular cardiomyocytes was carried out enzymatically applying a 
modified Langendorff apparatus, with which the heart tissue was anterogradely (through 
the coronary arteries) perfused, with solutions containing digestive enzymes. Each of the 
following steps was standardized and carried out under identical conditions in order to 
guarantee consistency of the outcome. 
The mice were anaesthetized in an exsiccator. After sedation, the animals were 
sacrificed by cervical dislocation and were fixed for dissection. From each dissected 
mouse, the heart was extracted in a cautious yet timely manner so that the tissue would 
stay as fresh as possible. The heart was then transferred to a Petri dish which was filled 
with EGTA-Tyrode´s solution. EGTA (Ethylene Glycol Tetraacetic Acid) had the function 
of binding the extracellular calcium ions and decreasing both the extracellular and 
intracellular calcium ionic concentration so that the autonomic myocardial contraction 
would cease during the course of the cell isolation and afterwards during the experiment. 
The composition of the solutions is described in Table 2.1 and 2.2. The solutions were 
prepared following the work of Tiemann et al. (2003) 
The aorta was then exposed under a stereo microscope. The surrounding tissue 
material, consisting mainly of connective tissue and lung parenchyma, was removed 
with small scissors, carefully so that the myocardium, coronary arteries, and the aorta 
could be kept undamaged. The aorta was cleanly cut at the distal end of the aortic arch. 
The opening of the aorta was then spread sideways with two small tweezers. The aorta 
was mantled on a glass cannula which was fixed on the Petri dish and had an outer 
diameter of 1.1 mm and an inner diameter of 0.8 mm.  
The aorta was pulled up so that the end of the glass cannula would be pushed into the 
lumen of the left ventricle, breaking the aortic semilunar valves. A silk thread was then 
wound around the aorta and the glass cannula proximal to the brachiocephalic artery 
and was tied so that the aorta was fixed on the glass cannula airtight (See Figure 3). 
The glass cannula with the heart was then taken off from its fixation and was docked 
onto the Langendorff perfusion system. It was made sure that the system, including the 
glass cannula, was air bubble free to prevent a possible air embolization of the coronary 
arteries. 
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Fig. 3: Mouse heart with aorta mantled on the glass 
cannula. The coronary arteries appear to be free of 
blood. 
 
1. coronary arteries 
2. Langendorff cannula 
 
 
 
 
 
 
 
 
Fig. 4: Langendorff perfusion system for cell 
isolation 
 
1. glass funnel 
2. high pressure chamber 
3. pressure regulator 
4. Langendorff cannula 
 
 
 
 
 
 
 
 
 
The Langendorff perfusion system had three main functions: oxygenation and warming 
up the perfusion solution up to 36 °C as well as creating the necessary perfusion 
pressure of 100 to 200 mm H2O (See Figure 4). 
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It consisted of a funnel with a glass frit which oxygenated the perfusion solution. When 
the connecting hose between the funnel and the high-pressure chamber was opened, 
the oxygenated solution flew into the chamber. During this flow, the pressure in the 
chamber was set equal to the air pressure outside the system, so that the solution would 
fill the chamber following gravitation. When the chamber was full, the connecting tube to 
the funnel was shut tight, and pressure was applied to the chamber. The heating device 
for the solution was a flexible rubber hose inside a second chamber that was supplied 
with circulating warm water from an external bath with a controlled heating system. The 
heating water from the bath and the perfusion solution were completely separated from 
each other. While flowing through the heating chamber the solution was warmed up to 
36°C. From there, a silicon hose led to the glass cannula connected to the heart so that 
the solution could be perfused into the coronary artery system while the pressure of the 
chamber was being applied. 
Two external lamps were used in order to keep the glass cannula and the heart surface 
warm as well because the room temperature was constantly at a lower level then 36°C, 
which would result in radiation of heat from the myocardial surface, causing it to become 
cooled down. The lamp’s position was also varied so that the ideal temperature level 
was reached. The temperature of the heart’s surface was controlled every 3 to 4 minutes 
so that 35-36°C could be kept consistently. 
Before the beginning of a Langendorff perfusion, a higher pressure was shortly applied 
to the system (ca. 5 s) so that the remaining blood in the heart lumens and the coronary 
arteries could be forced out in an attempt to guarantee a constant perfusion. After this, 
characteristically transparent coronary arteries filled with the clear solution could be 
observed by naked eye (See Figure 3). The pressure of the perfusion system was 
adjusted to the standard level (100 to 200 mm H2O) shortly after this initial maneuver 
and set to an appropriate perfusion speed. 
The perfusion speed and the temperature of the heart surface were constantly controlled 
in order to avoid overheating of the heart, which would result in: 1. an overly increased 
enzymatic activity, causing the cells to be “digested” rather than isolated, 2. heat 
induced reduction of the overall cell vitality. By adjusting the pressure level, an 
appropriate perfusion speed was chosen. Experience shows that keeping a constant 
temperature of between 34 and 36°C (with the optimum of 35°C, measured on the 
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surface of the heart with an electronic thermometer) resulted in the best isolated cells, 
qualitatively and quantitatively. 
In the initial phase of the perfusion, the heart was perfused with EGTA-Tyrode’s solution 
for 5 minutes (See Table 2 for exact composition). This would result in building calcium 
chelate complexes, reducing the extra cellular calcium level significantly. 
After this, a second solution was introduced to the system. To change the perfusion 
solution, the pressure system was halted and the remaining solution was let out of the 
chamber. After this, the already oxygenized new solution in the funnel could flow into the 
chamber. The solution was bubbled with 100% O2 for at least 30 seconds in order to 
guarantee a sufficient supply of O2 to the cardiomyocytes. The second solution con-
tained a potassium concentration equal to the cytoplasm (See Table 3 for exact 
composition). This increase of extra cellular potassium level resulted in a membrane 
potential of 0 mV and prevented potassium efflux from the cells. Fast sodium channels 
and voltage operated calcium channels became inactivated. The autonomous 
contraction of the cells ceased, reducing the energy consumption of the cells, leading to 
higher chance of survival. This second solution was applied for 5 minutes. 
 
Tab. 2: composition of EGTA-Tyrode solution and measurement Tyrode for the isolation, 
perfusion and measurement of cardiomyocytes 
Substance EGTA-Tyrode’s Measurement Tyrode’s 
KCl (Merck) 4 mM 4 mM 
NaCl (Merck) 135 mM 135 mM 
CaCl2 (Merck) - 1.8 mM 
MgCl2 (Merck) 1 mM 1 mM 
HEPES (Merck) 1 mM 1 mM 
BSA (Sigma) - 1 mg/ml 
Trypsin Inhibitor (Sigma) - 0.017 mg/ml 
Glucose (Merck) - 9 mM 
EGTA (Serva) 2.6 mM - 
pH (NaOH) 7.4 7.4 
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Tab. 3: composition of perfusion solutions with or without the addition of enzymes 
trypsin or collagenase 
Substance Potassium 
Solution 
Trypsin Solution Collagenase 
Solution KCl (Merck) 10 mM 10 mM 10 mM 
NaCl (Merck) 4 mM 4 mM 4 mM 
CaCl2 (Merck) 0.02 mM 0.02 mM 0.02 mM 
MgCl2 (Merck) 1 mM 1 mM 1 mM 
HEPES (Merck) 4 mM 4 mM 4 mM 
Glucose (Merck) 9 mM 9 mM 9 mM 
Potassium-glutamate 
Glutamate (Fluka) 
130 mM 130 mM 130 mM 
Trypsin (Roche) - 0.4 mg/ml - 
Collagenase Type L 
(Sigma) 
- - 0.375 mg/ml 
Polymyxin B (Sigma) - - 100 U/ml 
pH (KOH) 7.4 7.4 7.4 
 
Then, the actual enzymatic dissolving process of the cell-cell connections started. First, 
the heart was perfused with a trypsin solution for 10 minutes. While identical to the 
already mentioned potassium solution in its composition, it had an additional ingredient 
of 0.4 mg/ml trypsin (Roche, Mannheim), which is a digestive enzyme extracted from the 
cow’s pancreas. Trypsin dissolves specific peptide connections on the carboxyl group of 
Arginine or Lysine. With the introduction of trypsin solution to the system, the perfusion 
speed was significantly reduced, and the solution leaking from the heart increased in its 
viscosity dramatically which could be observed macroscopically. 
Thereafter, the potassium solution was again perfused shortly for 2 to 3 minutes in order 
to wash out the enzyme to prevent its prolonged activity. Now the collagenase enzyme 
solution was perfused into the heart for 10 to 12 minutes. This was, again, the potassium 
solution, this time, with the addition of collagenase Type L (Sigma-Aldrich, Steinheim, 
See Table 3). This enzyme was isolated from the gram-negative bacteria Clostridium 
histolyticum. This particular type of collagenase clears the specific peptide sequence of 
GLY-PRO-X-GLY-PRO, which occurs frequently in protein abundant collagen. X in the 
sequence can be any amino acid. Since the enzyme was isolated from gram-negative 
bacteria, it was feared that the solution might contain LPS contaminations. In order to 
eliminate this possible artifact, the solution was mixed with the Polymyxin B solution 
(Sigma-Aldrich, Steinheim) in a concentration of 100 U/ml. Polymyxin B is a peptide-
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antibiotic substance which consists of 11 amino acids. It has a high affinity to LPS and 
can bind free LPS particles, causing it to lose its toxicity (Warner et al., 1985). 
During the perfusion with the collagenase solution, the perfusion speed increased 
rapidly toward the end, which was taken as a sign of loosened cell-cell connections. 
After the Langendorff perfusion, an incision was made through the lower part of the 
heart in order to let out the remaining solution in the cardiac ventricles. The heart was 
detached from the glass cannula and transferred to a small glass beaker filled with 
measurement Tyrode’s solution at 36°C. The heart was then chopped up mechanically 
with a pair of small scissors. This suspension of shredded tissue and cells was run 
through a gauze filter into three glass centrifuge tubes in approximately equal volumes. 
The tubes were then centrifuged shortly so that each tube, in an ideal situation, 
displayed brown-pink colored pellet on the bottom. Now, each of the three pellets was 
mixed with the Tyrode’s solution. This new suspension was allowed to sediment for 10 
minutes. The color of the pellet turned to yellow. The pellet was resuspended and the 
solution with the cells was filled into a 36°C preheated Erlenmeyer flask with a Pasteur-
Pipette for the control measurement. The flask was provided with oxygen and was shut 
air-tight. 
 
2.2.2 Incubation of the Isolated Cells 
 
The remaining two groups of cells in two separate centrifuge tubes were prepared for 
incubation. Each group was mixed with 2 ml of culture medium (See Table 4). One 
group was administered with LPS (See 2.2.2.2), in order to simulate an infection caused 
by gram-negative bacteria. Both groups were stirred and were separately moved to Petri 
dishes with 5 cm diameter. These were then kept in an incubator at 37°C and an air CO2 
level of 5%. Our study group could already show in the past that the shortening length of 
murine cardiomyocytes under identical experimental conditions was not reduced even 
after 6 hours of incubation in the culture medium. (Baumgarten et al., 2006; 
Knuefermann et al., 2008). 
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2.2.2.1 The Culture Medium 
 
The culture medium is a short term culture medium, where the cells could survive up to 
12 hours under the given circumstances. The composition of the solution is to be seen 
on the Table 4. 
 
Tab. 4: composition of the short term culture medium for the ventricular cardiomyocytes 
Substance Provider Percentage 
Fetal Bovine Serum Gibco, Grand Island, NY, 
USA 
5% 
Minimal Essential Medium Gibco, Grand Island, NY, 
USA 
5% 
Gentamicin Gibco, Grand Island, NY, 
USA 
50 µg/ml 
Dulbecco’s Mean Eagle 
Medium 
Gibco, Grand Island, NY, 
USA 
ad 100% 
 
2.2.2.2 Lipopolysaccharide 
 
As mentioned in 2.2.2, a group of isolated cardiomyocytes was cultured with an addition 
of LPS (Sigma-Aldrich, St. Louis, MO, USA, L-3024) from the bacterium Escherichia 
coli-Serotype O111:B4. It consists of a Lipid A-component and a Polysaccharide chain 
(See Figure 2). The lyophilized and dry LPS powder was resuspended in Tyrode’s 
solution to a final concentration of 1 mg/ml and was stored at 4°C. Then, one Petri dish 
containing the isolated cells and 2 ml of culture medium was pipetted with 20 μl of the 
LPS solution so that the culture medium would have the LPS concentration of 10 μg/ml 
(See 4.1). 
 
2.2.3 Measurement of Sarcomere Shortening 
 
2.2.3.1 Experimental Setup 
 
The setup is displayed in Figure 5. 
The equipments that are needed for the measurement of sarcomere shortening are 
divided into three groups according to their functions. 
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1. Creating the optimal conditions for the cells during the measurement: 
The cells were brought into the center of a round and flat test chamber. A water 
circulatory system which was connected to the chamber guaranteed a constant 
temperature of 36 °C in the test environment. The supply of sufficient nutrition for 
the cells was obtained by a continuous perfusion with Tyrode’s solution. 
 
2. Generation of external electrical stimulation: 
A computer with the software Clampex® (Axon Instruments, Union City, CA, USA) 
was equipped with a Digital-Analog converter. It was connected to an electric 
pulse stimulator (SD 9, Grass Technologies, West Warwick, RI, USA) that could 
produce electrical stimuli with a predefined voltage and length. The stimulator was 
connected directly to the stimulation electrodes that reached into the perfusion 
solution in the measuring chamber with the cells. 
 
3. Registration and processing of the sarcomere shortening: 
The test chamber was placed on the stage of an inverted microscope. The cells 
were visualized by a special video camera (MyoCam, IonOptix, Milton, MA, USA). 
The video images were digitized and then transferred to a computer equipped 
with the IonWizard software (IonOptix). This software allowed to save the images 
in a file. The further processing is explained in Chapter 2.4. In order to eliminate 
possible vibration of the set up caused by an external force, for example by hand, 
the microscope was mounted on a shock absorbing table. This table consisted of 
a metal frame on which a stainless steel basin was placed on shock absorbing 
rubber dampers. The basin was filled with quartz sand which carried a 3 cm thick 
granite plate. This granite plate formed the desktop. 
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Fig. 5: Experimental Setup 
1 Microscope Axiovert 100 TV, 2 Ion Optix MyoCam, 3 Perfusion system, 4 Julabo F10 
warm bath, 5 HyoFlo suction pump, 6 Ion Optix HyperSwitch, 7 Transformer for the 
xenonlamp (not used during this experiment), 8 Ion Optix Fluorescense system interface 
(not used during this experiment), 9 Ion Optix camera control unit, 10 Amplifier, 11 
Control monitor for data acquisition, 12 Grass SD 9 stimulator, 13 Transformer for the 
lamp, 14 Control monitor for controlling of the electrical stimulation. 
 
2.2.3.2 Test Chamber 
 
The test chamber was manufactured out of acryl by the mechanic workshop of the 
Physiological Institute II (See Figure 6). It was circular and had an outer diameter of 
50 mm. It was fixated on the object stage of the microscope by screws. In the center of 
the measuring chamber was a hole of 10 mm diameter. On one side this hole was 
closed by a microscope cover slip, forming the bottom of the small chamber. The cover 
slip was attached to the experimental chamber using a two-component glue. The micro-
scopic cover slip allowed a visualization of the cells with microscopic objectives of high 
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resolution. To keep the temperature of the solution with the cells at 36 °C a small 
channel was milled around the central chamber for the cells. This channel was 
permanently perfused with warm water pumped by a heated water bath. The 
temperature of the water was controlled via a feedback loop with its sensor in the 
solution of the cells. A continuous perfusion with the above mentioned prewarmed 
Tyrode’s solution was provided for the cells during the course of the experiment. The 
inflow of the perfusate was driven by gravity, whereas the outflow was provided by 
application of negative pressure to a glass capillary. The inflow and the outflow speed 
were kept in a balance so that the fluid level in the chamber would stay as constant as 
possible. Through these mechanisms a consistent experimental environment could be 
provided so that the cells could be measured for about 30 minutes without deteriorating. 
 
Fig. 6: Test Chamber 
1. measuring area 
2. stimulation electrodes 
3. warm water outlet 
4. perfusion inlet 
5. temperature sensor 
6. warm water inlet 
7. glass suction capillary 
 
 
 
2.2.3.3 Coating of the Measuring Area with the Cardiomyocytes 
 
A continuing perfusion with measurement Tyrode’s solution and a continuing suction 
would cause the cells to drift away from their positions, making it impossible to measure 
their sarcomere shortening. In order to overcome this problem, the cells were adhered to 
the bottom of the measuring area by the protein laminin (Sigma-Aldrich), a major protein 
of the basal lamina. Laminin was dissolved in the measurement Tyrode´s at a concen-
tration of 8 µg/ml. Three drops of this solution were pipetted on the glass bottom of the 
measuring area. After 6 minutes, the fluid in the measuring area was sucked away. 
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Afterwards, the cell suspension was pipetted onto the measuring area. Another 6 
minutes were given so that the cells could attach themselves to the bottom with the help 
of laminin. The warm water circulation was turned off throughout this phase, because it 
would have resulted in overheating of the chamber otherwise, which would lead to 
deterioration of the cells. 
 
2.2.3.4 The Perfusion System 
 
In order to obtain a reliable, reproducible measurement results, it was essential to 
optimize the perfusion. The perfusion should not be too fast, lest the cells drift away, nor 
should it be too slow that the cells would not receive sufficient oxygen and nutrition. 
Moreover, the perfusion should be continuous and not periodical, therefore the suction 
also had to be continuous. Experience showed that an unbalanced perfusion normally 
results in irregular flow around the cells, causing the cells to detach from the bottom and 
to drift away. To build up a balanced flow, a reservoir of the perfusion solution was 
provided in a form of a holder for a 50 ml perfusion syringe which was mounted 30 cm 
above the measuring chamber, to establish a gravity gradient. The speed of the 
perfusion was regulated using an infusion drop regulator (Exadrop®, Braun, Melsungen) 
which was inserted between the syringe and the chamber. The speed was kept at 70 
drops per minute. Before entering the experimental chamber the perfusion buffer was 
warmed to 36 °C using a heat exchanger. The heat exchanger was coupled to the same 
water bath that supplied the measurement chamber. The negative pressure necessary 
for the suction of the perfusion solution was generated by a suction pump (HyoFlo, Herts, 
UK) which was connected to an empty jar with the capacity of about 10 liters. This jar 
was connected to the glass capillary by a silicon hose. 
 
2.2.3.5 The External, Electrical Stimulation 
 
In order to induce a controlled shortening of the cardiomyocytes, they were stimulated 
by electrical pulses to elicit action potentials. As mentioned above, this electrical 
stimulation was applied through two 0.8 mm thick gold wires that were parallel to each 
other and were fastened with an acryl molding. This was attached to a micro manipulator 
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so that the electrodes could be moved around in the measuring area. Under the 
microscopic control, the electrodes were positioned so that the cell to be measured was 
located between the electrodes. The electrodes were connected to an external stimu-
lator set. Each stimulus consisted of a voltage of 30 V and duration of 0.4 ms. The cells 
were stimulated with changing frequencies. There was a pause of 30 seconds between 
the stimulus trains. The respective order of the frequencies was 0.5, 10, 1, 8, 2, 6 and 4 
Hz. The trigger signal which drove the stimulator was given by the Clampex Software 
which was installed on a computer equipped with an Analog-to-Digital converter. Each 
stimulus train consisted of 20 pulses. 
 
2.2.3.6 β-Stimulation with Orciprenaline 
 
Orciprenaline, also known as metaproterenol, is a moderately selective β-adrenergic 
receptor agonist which mainly stimulates the β1-adrenoceptors but also β2-adrenoceptors 
to some degree. However, β2-adrenoreceptors are not expressed in the myocardium. By 
binding β1 adrenoceptors it contributes to stimulation of intracellular adenylylcyclase, the 
enzyme which catalyzes the conversion of ATP to cAMP. Increased cAMP levels are 
associated with the phosphorylation of sarcolemmal calcium channels and activating the 
calcium pump in the cardiomyocytes (Honerjäger, 1989). This causes an increase of 
intracellular calcium level, which results in the positive chronotropy, bathmotropy, 
dromotropy and inotropy. Orciprenaline found its use in the emergency medicine for 
intravenous application in patients with acute circulation failure. However, as more 
specific β1-adrenoreceptors (i.e. dobutamine) became available, its use has been limited 
to the treatment of acute asthma attacks. Orciprenaline was used in this study in the 
form of orciprenaline sulfate (Boehringer Ingelheim Pharma GmbH, Ingelheim am Rhein), 
mixed with the Tyrode’s solution in the concentration of 0.3 μg/ml which is the serum 
concentration of a normal patient of 75 kg after the intravenous application of one 
ampule of Alupent® in the emergency medicine. The Tyrode’s solution with orcipre-
naline was perfused through the experiment chamber during the stimulation of the 
cardiomyocyte. Orciprenaline was chosen in this study instead of other, more specific 
β1-agonists because of the stability against oxidation (instruction leaflet, Boehringer 
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Ingelheim) when used as solution and the easy access to the substance for experi-
mental purposes.  
 
2.2.4 The Principle of the optical Sarcomere Length Measurement 
 
Both skeletal and cardiac muscles belong to the cross-striated muscles, due to the 
characteristic pattern of the actin and myosin filaments in the sarcomere. Therefore, the 
cardiomyocytes exhibit a striated pattern of alternating dark and light bands in a light 
microscope. The distance between one dark band and the next resembles the length of 
a sarcomere. Through the video camera that was attached to the inverted light micro-
scope (Zeiss Axiovert 100 TV, Carl Zeiss, Oberkochen, Germany) the dark and bright 
bands in a defined area of interest of a cardiomyocyte could be displayed, registered 
and processed. The local distribution of the striation pattern was evaluated for its bright-
ness and thus transformed to a sinusoidal curve (See 3 in Figure 7). The wavelength of 
this sinusoidal curve was consistent with the respective sarcomere length (See Figure 7).  
 
 
 
 
 
 
 
 
 
Fig. 7: Video image of a cardiomyocyte with its power spectrum. Software IonWizard 
(IonOptix, Milton, MA, USA) 1. Cardiomyocyte, the scale (36 µm) indicates 20 
sarcomeres, 2. Region of interest, 3. Oscillation Curve, the scale (1.8 µm) indicates a 
single sarcomere length, 4. Power Spectrum (red line).  
 
The information from this wave was extracted by calculating a Fast-Fourier Transfor-
mation (See red line, Figure 7). The resulting power spectrum formed a peak at the 
absolute sarcomere length (See 4, Figure 7).  A sarcomere shortening caused the peak 
of the power spectrum to drift. The camera captured the images at a frequency of 240 
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Hz in order to follow the fast alterations of the sarcomere length during the murine action 
potential. 
Before the recording started, optimal cells were selected. An important criterion for the 
usability of the cells was the physiological, rectangular shape of the cell. By exact 
alignment of the sliding stage of the microscope and the camera angle, a cell was 
positioned so that the entire cell was displayed in the field of vision and the striation 
pattern was in line with the horizontal axis of the image. The cell was stimulated a 
couple of times by hand, using the manual function of the stimulator to make sure that 
the cell contracted properly without losing its adherence to the bottom of the chamber. 
Then, using the software, a region of interest was chosen. This rectangular area con-
tained the part of the cell that had well shaped sarcomere structure with good contrast. 
After this, the measurement and data acquisition could be initiated by starting the 
electrical stimulation program and the data acquisition program. 
 
2.3 Data Acquisition and Analysis 
 
The sarcomere shortening in the above mentioned frequency sequences was registered, 
recorded and analyzed with the help of the software IonWizard (IonOptix, Milton, MA, 
USA). 
 
2.3.1 Analysis of the Data Set Acquired during the Sarcomere Shortening 
 
The measured and calculated sarcomere lengths were saved as events on a timeline, in 
real time length of the experiment. This caused every stimulation frequency to have a 
characteristic appearance. The last five shortenings of a pulse train were marked 
manually and were averaged. Only the last five shortenings were taken into account, 
because our group (Tiemann et al., 2003, Baumgarten et al., 2006; Schumacher, 2006; 
Vervölgyi, 2007) has shown in previous studies that the early stimulations in a given 
pulse train is a part of the staircase and not in steady state. In addition, only the 
shortenings fulfilling the following criteria were taken (See Figures 8, 9, 10): All 20 
shortenings in a train had to be faultless, without spontaneous shortening in-between. In 
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addition, only the pulse trains were considered that did not have any shortening 
immediately before and after.  
 
 
 
 
 
 
 
Fig. 8: A plot of the average sarcomere shortening, calculated from the last five 
shortenings in a pulse train. The x axis represents time in seconds, the y axis the 
sarcomere length in μm. 
 
From this representative shortening, the program calculated five different parameters 
that were needed for the statistical analysis of the experiment:  the resting sarcomere 
length, the shortening amplitude, the shortening and relaxation speed, and the 
shortening duration. 
 
1. Resting Sarcomere Length 
The sarcomere length at a relaxed state could be measured by the program 
automatically. At lower stimulation frequencies, the cardiomyocytes had sufficient 
time to relax completely (usually < 6 Hz). At higher frequencies, however, the cells 
did not have enough time to return to their resting state, so that the program 
calculated a shorter resting sarcomere length here. This had to be corrected 
manually. 
 
2. Shortening Amplitude 
The shortening amplitude was calculated by IonWizard. The program took the 
difference between the resting sarcomere length and the minimum of a shortening 
curve. Because of the already mentioned phenomenon of the cells not returning fully 
to their resting length at higher frequencies, the shortening amplitude at these 
frequencies were not correctly calculated by the program. (See Figures 9, 10 and 11) 
Therefore, the difference between the manually measured resting sarcomere length 
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and the one measured by the program at these frequencies was added to the 
amplitude. 
 
Fig. 9:  
1 Hz, 
Baseline 
returning 
fully to the 
resting state 
position. The 
x axis 
represents 
time in 
seconds, the 
y axis the 
sarcomere 
length in μm. 
 
 
 
Fig. 10: 
10 Hz, 
Baseline not 
returning 
fully to the 
resting state 
position. The 
x axis 
represents 
time in 
seconds, the 
y axis the 
sarcomere 
length in μm. 
 
 
 
3. Shortening Speed 
The maximal shortening speed was calculated by the program. It was the maximum 
of the first derivative of the descending part of a shortening curve. 
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4. Relaxation Speed 
Similar to the shortening speed, this was calculated as the maximum of the first 
derivative of the ascending part of a curve by the program. 
 
5. Shortening Duration 
This was calculated by the program. It was the duration from the beginning of the 
contraction to the point where the sarcomere length had recovered to 90% of its 
original length. 
 
 
Fig. 11: IonWizard interface screen shot. On top of the screen a pulse train with 20 
shortenings at 1 Hz can be seen. From these, the last 5 were selected and plotted as a 
single graph. The graph and the average parameters are seen on the bottom of the 
screen. The numeric table can be exported as a data set. The x axis represents time in 
seconds, the y axis the sarcomere length in μm. 
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2.3.2 Statistics 
 
The numeric data sets produced by IonWizard were exported as text data (*.txt). They 
were then summarized into a Microsoft Excel Table using Igor® (WaveMetrics Inc., Lake 
Oswego, OR, USA) and were sorted into 6 groups. In addition, the mean and the 
standard deviation were calculated. Then, the data sets were statistically organized and 
were plotted using the software Prism 3.0 (GraphPad Software, San Diego, USA). In 
order to test the differences between groups, a multi factor variance analysis (two-way 
ANOVA) with the following Holm-Sidak multiple comparison test was performed with all 
6 groups at the same time. The arithmetic averages of the data sets were displayed as 
function of the standard error of the mean (SEM). The significance was defined as: 
 
p   > 0.05  not significant 
p   < 0.05  significant 
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3 Results 
 
3.1 The Number of Test Animals used 
 
A total of 49 test animals were used in this study. Only 33 successful preparations, 
delivering stable isolated cardiomyocytes were taken into the statistics. The reasons for 
the discrepancy are the following: First, some hearts and their coronary arteries were 
injured during the preparation so that the Langendorff perfusion was not possible to start 
with, since the “hole” somewhere on the myocardium or coronary artery let too much 
perfusion solution out. This made building up the necessary perfusion pressure 
impossible. Second, sometimes the excision of the aorta was too proximal to the heart 
so that mantling the heart on the glass cannula and fixing it with a thread was difficult. 
Third, the strict observation of the temperature and the perfusion speed during the 
Langendorff perfusion was not always successful. If, for instance, the temperature was 
above 39°C, the enzymes seemed to demonstrate greater activity than expected, so that 
the cardiomyocytes were literally “digested” which resulted in necrotic cells inadequate 
for in vitro experiments. On the other hand, if the temperature was below 35°C, the cell-
cell contacts were not fully dissolved so that the isolation itself was unsuccessful. With 
more experience and perfection of manual skills, these failures could be eliminated and 
reliable quality of isolated cells could be achieved regularly. 
 
3.2 Cell Groups 
 
As mentioned in 2.2, cardiomyocytes isolated from C57BL/6 mice in the age of between 
12 and 20 weeks were sorted into a total of three groups. The freshly isolated cells 
suspended in Tyrode’s solution made the first group. The remainder of the cells was 
incubated in culture mediums, separated in two groups, for 6 hours after which the 
experiment was performed. The cells of the first group were incubated with LPS. The 
second group was incubated without an addition of a stimulant but otherwise in same 
conditions. All three groups were tested under microscope with or without the influence 
of the β-receptor agonist Orciprenaline. Therefore, a total of 6 groups were tested and 
the statistical results are listed below. 
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3.3 Original Registrations 
 
To give an impression of the shortening behavior of the cardiomyocytes, averaged 
original recordings obtained in Tyrode´s solution (See Figure 12A) and after incubation 
in culture medium with LPS (See Figure 12B) are displayed. These representative 
stimulation frequencies were chosen to demonstrate the frequency dependent post-rest 
behavior (0.5, 6, 10 Hz, See Figures 12, 13, 14 and 15). In a pulse train, the first 
shortening after a resting state of 30 seconds (called the “post rest” shortening) always 
had the greatest amplitude. After this, the amplitudes of 0.5 Hz to 4 Hz showed a 
“negative staircase” pattern, which means that the amplitudes within a pulse train 
decreased until reaching the steady state (See Figure 12). Then, from 6 Hz onto higher 
frequencies, a “positive staircase” pattern could be observed (See Figure 14). This 
phenomenon is consistent to what our study group described earlier (Tiemann et al., 
2003). 
This switching from negative to positive staircase was not observed in cardiomyocytes 
stimulated with LPS. In culture medium, they showed a negative staircase pattern at all 
7 frequencies. Furthermore, the amplitude of shortening was clearly smaller after the 
incubation in culture medium with LPS (See Figure 14). 
To visualize the time course of the staircase the following function (3.1) was fitted to the 
minimum of the averaged shortenings. The time constants τ1 and τ2 characterize the 
steepness of the negative (τ1) and positive (τ2) staircase. 
 
 
y = (ss1 – (ss1 - postrest)-x/τ1) + (ss1 – ss2)-x/τ2 – (ss1 – ss2) 
 
Formula 3.1: Formula for the calculation of the time constant 
postrest: the minimum sarcomere length of the first Shortening after a resting state 
ss1: sarcomere length of the second shortening at the minimum 
ss2: sarcomere length at equilibrium (at 20th shortening at the minimum) 
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Fig. 12: Averaged original registrations of sarcomere shortenings of isolated 
cardiomyocytes of C57BL/6 mice during 20 external stimulations at 0.5 Hz. (A) shows 
the average of freshly isolated cells suspended in Tyrode’s solution (n=45). (B) shows 
the average of shortenings of cardiomyocytes incubated in culture medium with LPS for 
6 hours (n=18). Standard error is marked. The nonlinear regression curve was 
calculated with the formula 3.1. For both groups the “negative staircase” pattern can be 
seen. 
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Fig. 13: Averaged original registration of sarcomere shortenings of isolated 
cardiomyocytes of C57BL/6 mice during 20 external stimulations at 6 Hz. (A) shows the 
average of freshly isolated cells suspended in Tyrode’s solution (n=43). (B) shows the 
average of shortenings of cardiomyocytes incubated in culture medium with LPS for 6 
hours (n=11). Standard error is marked. After the post-rest shortening, both groups did 
not develop a staircase. Standard error is marked. 
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Fig. 14: Averaged original registrations of sarcomere shortenings of isolated 
cardiomyocytes of C57BL/6 mice during 20 external stimulation at 10 Hz. (A) shows the 
average of freshly isolated cells suspended in Tyrode’s solution (n=31). (B) shows the 
average of shortenings of cardiomyocytes incubated in culture medium with LPS for 6 
hours (n=15). Standard error is marked. The nonlinear regression curve was calculated 
with the formula 3.1. The group (A) shows a distinct “positive staircase” pattern. Group 
(B), on the other hand, did not develop a distinct staircase after the post-rest shortening. 
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Fig. 15: Averaged original registrations of sarcomere shortenings of isolated 
cardiomyocytes of C57BL/6 mice during 20 external stimulations at 0.5 Hz. (A) shows 
the average of shortenings of cardiomyocytes incubated in culture medium with LPS for 
6 Hours (n=18). (B) shows the average of shortenings of cardiomyocytes incubated in 
culture medium with LPS for 6 hours under β-stimulation with the addition of 
orciprenaline (n=24). Standard error margin is marked. The nonlinear regression curve 
was calculated with the formula 3.1. For both groups the “negative staircase” pattern can 
be seen.  
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3.4 Contraction Parameters 
 
The acquired parameters described in 2.3.1 are graphically portrayed below in order to 
demonstrate the characteristics of cardiomyocyte contraction for each group. 
 
3.4.1 Resting Sarcomere Length, Tyrode vs. Tyrode + Orciprenaline 
 
The sarcomere length at a relaxed state could be measured by the program 
(IonWizard®) automatically. The addition of orciprenaline in the concentration of 0.3 
μg/ml in Tyrode induced a small shortening of resting sarcomere at all tested 
frequencies (See Figure 16). However, this was not enough for a statistic significance. 
 
 
Fig. 16: The average resting sarcomere length (in µm ± SEM) of cardiomyocytes is 
plotted as function of the stimulation frequency in Hz. Significant differences could not 
be detected. The numbers of isolated cardiomyocytes used in each group are listed in 
Supplement 7.2. 
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3.4.1.1 Resting Sarcomere Length, Tyrode vs. Culture Medium + Orciprenaline 
 
The cultured group showed significant shortening of resting sarcomere at all tested 
frequencies. The incubated cells had a shorter resting sarcomere length compared to 
the freshly isolated cells suspended in Tyrode’s solution. The presence of orciprenaline 
in the concentration of 0.3 μg/ml in the cultured group induced a significant shortening of 
resting sarcomere at all tested frequencies compared to the group without orciprenaline. 
A significant frequency dependency could not be demonstrated (See Figure 17). 
 
 
Fig. 17: The average resting sarcomere length (in µm ± SEM) of cardiomyocytes is 
plotted as function of the stimulation frequency in Hz. (significance * marked for Tyrode 
vs. Culture Medium + Orciprenaline; significance # marked for Culture Medium vs. 
Culture Medium + Orciprenaline; significance x marked for Tyrode vs. Culture Medium) 
The numbers of isolated cardiomyocytes used in each group are listed in Supplement 
7.2. 
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3.4.1.2 Resting Sarcomere Length, Culture Medium + LPS vs. Culture Medium + 
LPS + Orciprenaline 
 
The presence of LPS in the culture medium had no influence on the resting sarcomere 
length. After the addition of orciprenaline in the concentration of 0.3 μg/ml in the cultured 
group with LPS, a small difference in the shortening of the resting sarcomere length was 
observed, but not enough for a statistical significance (See Figure 18). 
 
 
Fig. 18: The average resting sarcomere length (in µm ± SEM) of cardiomyocytes is 
plotted as function of the stimulation frequency in Hz. (significance * marked for Culture 
Medium vs. Culture Medium + LPS; significance # marked for Culture Medium vs. 
Culture Medium + LPS + Orciprenaline) The numbers of isolated cardiomyocytes used 
in each group are listed in Supplement 7.2. 
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3.4.2 Sarcomere Shortening Amplitude, Tyrode vs. Tyrode + Orciprenaline 
 
The shortening amplitude was calculated by IonWizard. The program calculated the 
difference between the resting sarcomere length and the minimum of a shortening curve. 
The function of shortening amplitude and frequency exhibited a biphasic shape with a 
local maximum at low stimulation frequencies, a minimum at 2 Hz and a high plateau at 
stimulation frequencies ≤ 6 Hz. The addition of orciprenaline in the concentration of 
0.3 μg/ml significantly increased the shortening amplitude of the cells by 0.1 μm - 0.15 
μm at all stimulated frequencies. The shortening amplitude rose in the average of 135.6 % 
(See Figure 19). 
 
 
Fig. 19: The average sarcomere shortening amplitude (in µm ± SEM) of cardiomyocytes 
is plotted as function of the stimulation frequency in Hz. (significance * marked for 
Tyrode vs. Tyrode + Orciprenaline) The numbers of isolated cardiomyocytes used in 
each group are listed in Supplement 7.3. 
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3.4.3 Sarcomere Shortening Speed, Tyrode vs. Tyrode + Orciprenaline 
 
Analogue to the frequency dependence of the shortening amplitude, the shortening 
speed also showed a biphasic pattern with a minimum around 2 Hz - 4 Hz and the peak 
at around 6 Hz - 8 Hz (See Figure 20). The addition of orciprenaline in the concentration 
of 0.3 μg/ml in the freshly isolated Tyrode group induced a significant increase in 
shortening speed at all tested frequencies. The shortening speed rose in the average of 
62.4 %. The biphasic pattern became more apparent as well. 
 
 
Fig. 20: The average sarcomere shortening speed (in µm/s ± SEM) of cardiomyocytes is 
plotted as function of the stimulation frequency in Hz. (significance * marked for Tyrode 
vs. Tyrode + Orciprenaline) The numbers of isolated cardiomyocytes used in each group 
are listed in Supplement 7.4. 
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3.4.4 Sarcomere Relaxation Speed 
 
Analogue to the shortening speed, the tangential line drawn on the steepest ascending 
part of a shortening curve was taken as the slope of a given shortening to calculate the 
relaxation speed. The curves also showed a biphasic pattern with the low point at 2 Hz 
and the high point at around 6 Hz – 8 Hz while the pattern was not as distinctive as in 
other parameters. The cells incubated in culture medium had lower relaxation speed 
than in the freshly isolated Tyrode group. 
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3.4.4.1 Relaxation Speed, Tyrode vs. Tyrode + Orciprenaline 
 
The presence of orciprenaline in the concentration of 0.3 μg/ml induced a significant 
increase in relaxation speed at all tested frequencies. The relaxation speed rose in the 
average of 57.8 %. The biphasic pattern became more apparent as well, for example at 
8 Hz (See Figure 21). 
 
 
Fig. 21: The average relaxation speed (in µm/s ± SEM) of cardiomyocytes is plotted as 
function of the stimulation frequency in Hz. (significance * marked for Tyrode vs. Tyrode 
+ Orciprenaline) The numbers of isolated cardiomyocytes used in each group are listed 
in Supplement 7.5. 
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3.4.5 Sarcomere Shortening Amplitude in Culture Medium 
 
The incubation of the cells in culture medium for 6 hours reduced the shortening 
amplitude significantly, which was by 28.7% in average. The addition of orciprenaline in 
the concentration of 0.3 μg/ml to the culture medium increased the shortening amplitude 
significantly at all stimulation frequencies. Under these conditions the shortening 
amplitude significantly exceeded that of freshly isolated cells in Tyrode´s solution. The 
stimulating effect of orciprenaline in culture medium amounted to 97.5 % in average 
(See Figure 22). 
 
 
Fig. 22: The average sarcomere shortening amplitude (in µm ± SEM) of cardiomyocytes 
is plotted as function of the stimulation frequency in Hz. (significance marked * for 
Tyrode vs. Culture Medium; significance # marked for Culture Medium vs. Culture 
Medium + Orciprenaline; significance x marked for Tyrode vs. Culture Medium + 
Orciprenaline) The numbers of isolated cardiomyocytes used in each group are listed in 
Supplement 7.3. 
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3.4.5.1 Sarcomere Shortening Amplitude, Tyrode + Orciprenaline vs. Culture 
Medium + Orciprenaline 
 
When the shortening amplitude of freshly isolated cells with orciprenaline was compared 
with the shortening amplitude of incubated cells with orciprenaline, there were some 
significant differences, but not at all frequencies. The level reached in culture medium 
with orciprenaline remained still below that of freshly isolated cells in Tyrode solution 
with orciprenaline (See Figure 23). 
 
 
Fig. 23: The average sarcomere shortening amplitude (in µm ± SEM) of cardiomyocytes 
is plotted as function of the stimulation frequency in Hz. (significance marked * for 
Tyrode + Orciprenaline vs. Culture Medium + Orciprenaline) The numbers of isolated 
cardiomyocytes used in each group are listed in Supplement 7.3. 
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3.4.6 Sarcomere Shortening Speed, Culture Medium + Orciprenaline vs. Tyrode vs. 
Culture Medium 
 
The incubation of the cells in culture medium for 6 hours reduced the shortening speed 
significantly. The addition of orciprenaline in the concentration of 0.3 μg/ml to the culture 
medium increased the shortening speed significantly at most stimulation frequencies. 
Under these conditions the shortening speed significantly exceeded that of freshly 
isolated cells in Tyrode´s solution. The stimulating effect of orciprenaline in culture 
medium amounted to 82.3 % in average (See Figure 24). 
 
 
Fig. 24: The average sarcomere shortening speed (in µm/s ± SEM) of cardiomyocytes is 
plotted as function of the stimulation frequency in Hz. (significance marked * for Tyrode 
vs. Culture Medium; significance marked # for Culture Medium vs. Culture Medium + 
Orciprenaline; significance marked x for Tyrode vs. Culture Medium + Orciprenaline) 
The numbers of isolated cardiomyocytes used in each group are listed in Supplement 
7.4. 
  
0.5 1 2 4 6 8 10
0
4
6
8
Stimulation Frequency (Hz)
[µ
m
/s
]
Sarcomere Shortening Speed CM + Orci vs. Tyrode vs. CM
Tyrode  
CM + Orci
CM
*
# # # ## #
x x x xx x
  
 
 
53 
3.4.7 Relaxation Speed, Tyrode vs. Culture Medium vs. Culture Medium + 
Orciprenaline 
 
Similarly, the incubation of the cells in culture medium for 6 hours reduced the relaxation 
speed significantly in many stimulation frequencies. The addition of orciprenaline in the 
concentration of 0.3 μg/ml to the culture medium increased the relaxation speed 
significantly at all frequencies, in the average of 276.8 %. Under these conditions the 
relaxation speed significantly exceeded that of freshly isolated cells in Tyrode solution 
(See Figure 25). 
 
  
Fig. 25: The average relaxation speed (in µm/s ± SEM) of cardiomyocytes is plotted as 
function of the stimulation frequency in Hz. (significance marked * for Tyrode vs. Culture 
Medium; significance marked # for Culture Medium vs. Culture Medium + Orciprenaline; 
significance marked x for Tyrode vs. Culture Medium + Orciprenaline) The numbers of 
isolated cardiomyocytes used in each group are listed in Supplement 7.5. 
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3.4.8 Sarcomere Shortening Amplitude, Culture Medium vs. Culture Medium + LPS 
vs. Culture Medium + LPS + Orciprenaline 
 
Addition of orciprenaline elevated the shortening amplitude in the Culture Medium + LPS 
+ Orciprenaline group at all tested frequencies compared to Culture Medium + LPS 
group. Addition of orciprenaline elevated the shortening amplitude in the Culture Medium 
+ LPS + Orciprenaline group even above the Culture Medium control group. Level of 
significance was reached at the frequencies 0.5, 1, 2, 6, 8 and 10 Hz. The shortening 
amplitude rose here in the average by 124.9 %. The negative effect of LPS on 
shortening amplitude of incubated cells could be demonstrated significantly only at 8 Hz 
(See Figure 26). 
 
Fig. 26: The average sarcomere shortening amplitude (in µm ± SEM) of cardiomyocytes 
is plotted as function of the stimulation frequency in Hz. (significance marked * for 
Culture Medium + LPS vs. Culture Medium + LPS + Orciprenaline; significance marked 
# for Culture Medium vs. Culture Medium + LPS + Orciprenaline; significance marked x 
for Culture Medium vs. Culture Medium + LPS) The numbers of isolated cardiomyocytes 
used in each group are listed in Supplement 7.3.   
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3.4.9 Sarcomere Shortening Amplitude, Culture Medium + Orciprenaline vs. 
Culture Medium + LPS + Orciprenaline 
 
The addition of orciprenaline in the concentration of 0.3 μg/ml induced a significant 
increase in shortening amplitude in the Culture Medium + Orciprenaline group (Culture 
Medium vs. Culture Medium + Orciprenaline) at all frequencies and in the Culture 
Medium + LPS + Orciprenaline group (Culture Medium vs. Culture Medium + LPS + 
Orciprenaline) in the frequencies 0.5, 1, 2, 6, and 8 Hz. The effect of orciprenaline in 
both incubated groups was so prominent, that there wasn´t a significant difference in the 
shortening amplitude in any frequency between Culture Medium + Orciprenaline group 
and Culture Medium + LPS + Orciprenaline group (See Figure 27).  
 
  
Fig. 27: The average sarcomere shortening amplitude (in µm ± SEM) of cardiomyocytes 
is plotted as function of the stimulation frequency in Hz. (significance marked * for 
Culture Medium vs. Culture Medium + Orciprenaline; significance marked # for Culture 
Medium vs. Culture Medium + LPS + Orciprenaline) The numbers of isolated 
cardiomyocytes used in each group are listed in Supplement 7.3.  
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3.4.10 Sarcomere Shortening Speed, Culture Medium vs. Culture Medium + LPS vs. 
Culture Medium + LPS + Orciprenaline 
 
The addition of orciprenaline in the incubated group with LPS in the concentration of 
0.3 μg/ml induced a significant increase in shortening speed at all tested frequencies 
(Culture Medium + LPS vs. Culture Medium + LPS + Orciprenaline). The shortening 
speed rose here in the average of 175.9 %. There was a significant difference in the 
shortening speed between Culture Medium group and Culture Medium + LPS + 
Orciprenaline group at the frequencies 0.5, 1, 2 and 4 Hz. The effect of LPS on the 
shortening speed of incubated cells could be demonstrated significantly only at 0.5 Hz 
(See Figure 28).  
 
 
Fig. 28.: The average sarcomere shortening speed (in µm/s ± SEM) of cardiomyocytes 
is plotted as function of the stimulation frequency in Hz. (significance marked * for 
Culture Medium + LPS vs. Culture Medium + LPS + Orciprenaline; significance marked 
# for Culture Medium vs. Culture Medium + LPS; significance marked x for Culture 
Medium vs. Culture Medium + LPS + Orciprenaline) The numbers of isolated 
cardiomyocytes used in each group are listed in Supplement 7.4. 
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3.4.11 Sarcomere Shortening Speed, Culture Medium + Orciprenaline vs. Culture 
Medium + LPS + Orciprenaline 
 
After the addition of orciprenaline in all incubated groups in the concentration of 
0.3 μg/ml, a tendency of increase in in shortening speed could be observed. However, 
there was no statistically significant difference between Culture Medium + Orciprenaline 
group and Culture Medium + LPS + Orciprenaline group (See Figure 29). 
 
 
Fig. 29.: The sarcomere shortening speed (in μm/s) of cardiomyocytes is plotted as 
function of the stimulation frequency in Hz with average ± standard error. There was no 
significant difference in shortening speed between Culture Medium + Orciprenaline 
group and Culture Medium + LPS + Orciprenaline group. The numbers of isolated 
cardiomyocytes used in each group are listed in Supplement 7.4. 
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3.4.12 Sarcomere Relaxation Speed, Culture Medium vs. Culture Medium + LPS vs. 
Culture Medium + LPS + Orciprenaline 
 
The addition of orciprenaline in Culture Medium + LPS + Orciprenaline group in the 
concentration of 0.3 μg/ml induced a significant increase in relaxation speed at the 
frequencies 0.5, 1, 2, 4, and 6 Hz, in the average of 131.6 % when compared to Culture 
Medium + LPS group. Culture Medium + LPS + Orciprenaline group also showed a 
significant increase of the relaxation speed when compared to Culture Medium group at 
the frequencies 0.5, 1, 6 and 8 Hz. The negative effect of LPS on shortening amplitude 
of incubated cells could not be demonstrated significantly at all frequencies (See Figure 
30). 
 
 
Fig. 30.: The average relaxation speed (in µm/s ± SEM) of cardiomyocytes is plotted as 
function of the stimulation frequency in Hz. (significance marked * for Culture Medium + 
LPS + Orciprenaline vs. Culture Medium + LPS; significance marked # for Culture 
Medium vs. Culture Medium + LPS + Orciprenaline) There was no significant difference 
between Culture Medium and Culture Medium + LPS group. The numbers of isolated 
cardiomyocytes used in each group are listed in Supplement 7.5. 
0.5 1 2 4 6 8 10
0
2
4
Stimulation Frequency [Hz]
[µ
m
/s
]
Relaxation Speed CM vs. CM + LPS vs. CM + LPS + Orci
CM
CM + LPS + Orci
CM + LPS
* * * * *
# #     # # # #
* *
#
  
 
 
59 
4 Discussion 
 
The advancement of modern medicine has brought about many possibilities in treating 
patients with sepsis. Still, septic cardiomyopathy remains to be a major cause of death in 
patients suffering from the complications of sepsis and septic shock. About 45% of all 
patients with diagnosed septicemia develop an acute septic cardiomyopathy, which has 
a mortality rate up to 70% (Charpentier et al., 2004; Schuster and Müller-Werdan, 2000). 
The object of this study was to observe the influence of LPS on the shortening of 
isolated cardiomyocytes in vitro, simulating a septic cardiomyopathy. Furthermore, the 
influence of orciprenaline, a β-stimulation agent, on the shortening of septic cardio-
myocytes was observed and the result was compared to the control group. 
 
4.1 Validity of the Method 
 
In order to rate the validity of the methods applied in this study it is necessary to 
evaluate the quality and the reliability of the cell isolation and measuring methods. The 
techniques used in this study were repeatedly and successfully adopted in many 
different studies done by our group on various species of animals such as guinea pig, rat, 
rabbit and mouse (Linz and Meyer, 2000; Meyer, 1989; Tiemann et al., 2003). In mouse, 
different genotypes were tested (Baumgarten et al., 2006; Kempelmann, 2005; Tiemann 
et al., 2003; Vervölgyi, 2007). The results of the cell isolation in this study were 
consistently acceptable. Quantitatively, about 70% of all cells isolated were vital and 
usable. Qualitatively, most of the vital cells showed the characteristics of healthy 
cardiomyocytes (rod-shaped, intact cell poles and regular distribution of sarcomere 
bands). In order to preserve qualities of the isolated cells for 6 hours under various 
conditions (e.g. stimulation with LPS), the cells were incubated in a culture medium. This 
specific mixture of four main ingredients (See 2.2.2.1) is based on the description of long 
term incubating culture medium for isolated cardiomyocytes (Clark et al., 1998; He et al., 
1996) and has been successfully and reliably applied by our study group (Baumgarten et 
al., 2006; Knuefermann et al., 2008; Lohner et al., 2013). However, the resting 
sarcomere length of all incubated cells was significantly and evenly reduced compared 
to the freshly isolated cells. This was a predictable phenomenon, already described in 
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previous studies (Baumgarten et al., 2006; Vervölgyi, 2007). Even though culture 
medium was applied to stabilize the quality of the cardiomyocytes, their shortening 
amplitude was significantly reduced compared to the freshly isolated cells in Tyrode’s 
solution (Fig. 22). 
The electrical stimulation pattern of 7 different frequencies was chosen for the following 
reasons. First of all, there should be a 30 second pause between every pulse train, so 
that the cells were in a comparable state before each stimulation train. The alternating 
pattern of low and high frequencies (in the order of 0.5, 10, 1, 8, 2, 6 and 4 Hz) was 
designed to eliminate any influence of high or low frequency stimulation on the next 
pulse train. The highest frequency in a pulse train was 10 Hz, which was already used 
by Tiemann et al. (2003). They were able to measure a physiological heart rate of up to 
580 ± 11/min. in living mice under control conditions. This is an equivalent of about 9.6 
Hz. Therefore, a shortening frequency of 10 Hz has to be regarded as physiological in 
murine cardiomyocytes. It should be noted that only a cell of a good quality can survive 
an electrical stimulation at 10 Hz, especially when it has already been exposed to stress 
situations, such as enzymatic isolation, incubation and additional exposure to 
pathogenic agents like LPS. A stimulation of a cell not fulfilling the criteria of the above 
described quality (for example, shape, size and sarcomere structure) often resulted in 
necrosis of the given cell during the stimulation. The majority of publications concerning 
similar experimental methods did not demonstrate stimulation at high frequencies such 
as 8 Hz and 10 Hz which speaks for the good quality of the cells used in our study group. 
Furthermore, the absolute sarcomere length was optically measured and was used for 
the parameters in this study. This method is independent of the cell size and provides a 
crucial advantage over the often used “edge detection” technique where the shifting of 
the cell edge represents the degree of cell shortening. Since the cell size of murine 
cardiomyocytes varies, the edge detection method requires the normalization of the 
shortening amplitude to the cell length. This additional step could be omitted by using 
the sarcomere length measurement. 
The LPS concentration used for the incubation (10 μg/ml) was chosen because it could 
be shown in the past (Kinugawa et al., 1997; Wagner et al., 1998) that the LPS-
stimulation of murine cardiomyocytes at this concentration had a noticeably depressive 
effect on the cells without causing a necrosis, therefore simulating a sepsis caused by 
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gram-negative bacteria. Since then, this concentration has been used in our study group 
repeatedly (Baumgarten et al., 2006; Vervölgyi, 2007). In order to avoid a possible 
contamination by LPS already during the isolation process through the use of 
collagenase isolated from the gram-negative bacterium Clostridium histolyticum (See 
2.2.1), the collagenase solution was mixed with Polymyxin B, a peptide-antibiotic 
substance which binds free LPS particles, depressing its toxicity (Warner et al., 1985). 
The time frame in which the incubated cells could be stimulated and measured was 5 to 
8 hours after the isolation. This was based on earlier results of Baumgarten et al. (2006) 
which showed that the maximum negative influence of LPS on cell shortening was 
detected after 5 hours of incubation. Therefore, an incubation time of 6 hours was 
chosen in this study so that a maximum effect of LPS was expected and there were still 
2 hours remaining for the measurements.  
 
4.2 The effects of orciprenaline on the shortening of cardiomyocytes 
 
Since the description of the positive chronotropic effect of epinephrine in the 1940s 
(Barcroft et al., 1949), the positive effect of catecholamine on the contractility of the 
heart, even on the molecular level, has been researched often and understood in detail 
(Review: Mann, 2015; Shanks et al., 1967). In our study, it has also been shown that the 
addition of the β1 agonist orciprenaline at the concentration of 0.3 μg/ml resulted in a 
significant improvement of the shortening in all cell groups to which it had been added 
(Tyrode, Culture Medium, Culture Medium + LPS). This result correlated to a previous 
study of our group (Weisser-Thomas et al., 2015). In their study, orciprenaline induced a 
significant concentration-dependent positive inotropic effect in myocytes of wildtype mice, 
causing a rise of sarcomere shortening by 161.2% in Tyrode at 0.5 Hz at the 
orciprenaline concentration of 0.25 µg/ml vs. 0.3 µg/ml here. At 0.5 Hz, e.g., the addition 
of orciprenaline caused an elevation of shortening amplitude in the Tyrode group by 
142.3 %. Culture Medium group showed an elevation of shortening amplitude by 182.5 % 
at 0.5 Hz. Thus, the results of the present study confirmed the previous results of our 
study group. This further underlines that the cells used in this study were in good 
physical condition.  
 
  
 
 
62 
4.3 Signal Cascade from TLR4 to Cardiac Depression in the Presence of 
Lipopolysaccharide 
 
The reduction of cardiac contractility in the form of a septic cardiomyopathy is a frequent 
and serious complication of a severe sepsis. Since the isolation of Lipopolysaccharide in 
1943 (Shear and Turner, 1943), it has been shown that LPS is an essential component 
of the outer cell membrane of the most gram-negative bacteria and one of the strongest 
known immune stimulating substances (Alexander and Rietschel, 2001). 
In a preceding study, Baumgarten et al. (2006) demonstrated that 10µg/ml LPS applied 
to isolated cardiomyocytes of CH3/HeN mice was able to suppress the sarcomere 
shortening via the TLR4 pathway. This suppression of sarcomere shortening could be 
prevented by application of the TLR4 antagonist Eritoran or by application of SMT (S-
methylisothiourea), an iNOS blocker. This showed that iNOS and NO are involved in the 
TLR4 dependent decrease of cardiac sarcomere shortening. 
Ullrich et al. (2000) could show that iNOS deficient mice (chromosome 17) did not show 
any relevant cardiac depression after having been exposed to bacterial endotoxin. 
Furthermore, Vervölgyi (2007) of our study group showed that LPS also affected the 
contractility of cardiomyocytes by reducing the calcium sensitivity. This finding was 
supported by earlier resuIts of Rastaldo et al. (2007) and Massion and Balligand (2003) 
who demonstrated that high concentrations of nitric oxide (NO) impair cardiac function 
through activation of protein kinase G followed by Ca2+ desensitization of troponin 
(Ehrentraut et al., 2011). 
In addition, it was demonstrated that block of iNOS by SMT was also able to restore the 
reduced sarcomere shortening after TLR9 stimulation (Knuefermann et al., 2008).  
In the present study, LPS also significantly depressed sarcomere shortening amplitude 
as well as shortening and relaxation speed of C57BL/6 cardiomyocytes. Although 
sarcomere shortening amplitude was significantly reduced only at 8 Hz stimulation 
frequency, also the values of 4 and 6 Hz were lower than those of control and the shape 
of the graph had changed completely. However, in this study, the depressive effect of 
LPS on the shortening of the C57BL/6 cardiomyocytes was less prominent than in the 
cardiomyocytes isolated from C3H/HeN mice. 
There are four possible explanations for this phenomenon. First, the LPS used in this 
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study (Sigma-Aldrich, St. Louis, MO, USA, L-3024, see 2.2.2.2) could have had a 
different virulence, because the Lipid A-component of LPS may vary, depending on the 
type of bacterium from which it has been isolated. This possibility, however, could be 
eliminated because here the same LPS from Sigma-Aldrich, isolated from the bacterium 
Escherichia coli-Serotype O111:B4 was applied as in all our previous studies. 
The second possible explanation is that the cells became insensitive to LPS due to an 
early exposure to LPS already during the isolation process because of a possible 
contamination of the collagenase which was isolated from Clostridium histolyticum. 
However, as mentioned in 4.1, the use of Polymyxin B in the isolation process should 
bind free LPS particles, inactivating the possible toxicity. This method had also been 
applied in our previous studies, therefore we think that lower LPS sensitivity by pre-
exposure of the cells is not plausible.  
The third explanation is that the phenomenon could be attributed to the different strain of 
mice investigated. The strain of mice used in this study (C57BL/6) may have been less 
sensitive to LPS in comparison to the mouse type C3H, which was used in our previous 
studies (Ehrentraut et al., 2011; Vervölgyi, 2007). It has been observed by other study 
groups that C57BL/6 mice were less sensitive to the stimulus of LPS than BALB/c mice 
(Oliveira et al., 2014, Santos et al., 2006).  
The fourth, and the most likely, explanation is that the Culture Medium group had a 
smaller shortening amplitude than was detected previously (Baumgarten et al., 2006). 
This resulted in a smaller signal to noise ratio in the Culture Medium + LPS group. 
Furthermore, the observation that LPS application also significantly reduced the 
shortening speed at low stimulation frequencies underlines that LPS had a clear 
negative inotropic effect on the C57BL/6 cardiomyocytes. 
 
4.4 “Rescue Effect” of Orciprenaline in the Presence of LPS 
 
As shown in 4.3, the incubation with LPS caused a significant depression of sarcomere 
shortening. After addition of orciprenaline to the LPS incubated group, the sarcomere 
shortening not only recovered but even significantly exceeded that of the control group. 
This positive, “rescue effect” due to orciprenaline on the sarcomere shortening was so 
prominent, that the shortening amplitudes reached the same level as those after 
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orciprenaline without LPS pre-treatment (See Figure 27). Thus, β-stimulation seems to 
be sufficient to overcome the negative inotropic influences of LPS. However, it is well 
known that the effect of β-stimulation does not last for a long time because of β receptor 
desensitization (Freedman et al., 1995). In this study, it could be shown that LPS 
stimulation can be completely overcome by beta stimulation in single isolated 
cardiomyocytes. I.e. the antagonistic effect of LPS and beta stimulation act on the single 
cell level in the heart. β-stimulation was able to rule out the LPS effect completely on the 
same cell. Thus, the aim of this study to quantitatively characterize the influence of β-
stimulation and LPS intoxication on single cells can be considered as met. 
 
4.5 Conclusion 
 
In this study, the negative effect of LPS on sarcomere shortening was demonstrated. It 
was also shown that the addition of orciprenaline could compensate for the depressive 
effect of LPS fully. Interestingly, LPS pre-treated cells reacted so strong to β-stimulation, 
that they were able to shorten with same amplitude as the control group after β-
stimulation. 
As mentioned in the introduction, septicemia and septic shock are responsible for many 
complications leading to most deaths in Intensive Care Unit (ICU) patients. A bacterial 
septicemia can lead to septic cardiomyopathy and septic vascular leakage, which then 
causes a circulation failure and eventually the death of a patient (Ramirez et al., 2017). 
Therefore, the question whether or not to initiate a catecholamine therapy in a septic 
patient possesses a high clinical relevance. In every day ICU setting, the catecholamine 
therapy is readily applied to a septic patient in order to sustain the blood pressure of the 
patient, which is an indisputable priority. This study proved that the above mentioned 
“rescue effect” of a β-stimulation was able to completely reverse the negative influence 
of LPS on shortening even on the level of isolated cardiomyocytes. This may, in part, 
explain the benefit of the catecholamine therapy in patients. Furthermore, in patients, 
this therapy does not only improve myocardial contractility and ejection fraction of the 
heart in the whole, but also has a vasocontractile effect through the stimulation of -
receptors. The combination of these two effects can be expected to lead to a more 
positive effect on the blood pressure of the patient in the medication-based circulation 
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management. The present study was able to extend a clinically proven therapy of septic 
cardiomyopathy to the level of single cardiomyocytes. 
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5 Zusammenfassung 
Die septische Kardiomyopathie geht mit einer hohen Morbidität und Mortalität einher. In 
der Sepsis wird die Kontraktilität der einzelnen Kardiomyozyten stark vermindert. Die 
Pumpleistung des Herzens als Gesamtorgan reduziert sich somit massiv. Etwa ein 
Fünftel aller septischen Patienten sterben aufgrund des herabgesetzten kardialen 
Auswurfs (Engl. „low cardiac output syndrome“) unter septischer Kardiomyopathie. Ein 
solcher intensivpflichtige Patient bedarf in der Regel einer prolongierten hochdosierten 
Katecholamintherapie. In dieser Studie wurde der Einfluss von Katecholaminen auf die 
Kontraktilität einzelner septischer Kardiomyozyten experimentell untersucht mit der 
Hypothese, dass die in vivo gezeigte Aufhebung der kardialen Depression durch 
Katecholaminen auch auf einer Verbesserung der Verkürzung einzelner Kardiomyozyten 
beruht. Es wurden Kardiomyozyten aus dem Arbeitsmyokard von C57BL/6 Mäusen 
durch die Langendorff-Perfusionstechnik isoliert. Danach wurde eine Gruppe der Zellen 
in Kulturmedium mit Lipopolysaccharid (LPS) sechs Stunden lang inkubiert, um eine 
bakterielle Sepsis zu simulieren. Die zweite Gruppe wurde in Kulturmedium ohne LPS 
sechs Stunden lang inkubiert. Anschließend wurden beide Gruppen in verschiedenen 
Frequenzen elektrisch stimuliert. Die Stimulation erfolgte jeweils mit oder ohne Perfusion 
von Orciprenalin, ein nicht-selektives β-Sympathomimetikum, um die Katecholamin-
therapie in einer septischen Kardiomyopathie zu simulieren. Die Sarkomerverkürzung 
der jeweiligen Zellen wurde lichtmikroskopisch registriert. Daraus wurden die folgenden 
Parameter numerisch erfasst: Ruhesarkomerlänge, Verkürzungsamplitude, Verkür-
zungsgeschwindigkeit und Relaxationsgeschwindigkeit.  
Durch diese Studie konnte zunächst die depressive Wirkung von LPS auf die Sarkomer-
verkürzung demonstriert werden, analog zu den vorherigen Ergebnissen unserer 
Arbeitsgruppe. Des Weiteren konnte gezeigt werden, dass diese Beeinträchtigung der 
Sarkomerverkürzung unter Einsatz von Orciprenalin nicht nur teilweise aufgehoben, 
sondern sogar überkompensiert wird. Damit konnte der „Rettungseffekt“ einer Katechol-
amintherapie in einer septischen Kardiomyopathie vermittelt durch die β-Stimulation 
demonstriert werden. Es konnte somit die o.g. Hypothese bestätigt werden. 
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7 Supplement: Tables of Measured Parameters 
 
7.1 Legend 
 
Hz   Stimulation Frequency 
Mean   Mean 
SD   Standard Deviation 
n   number of cells tested 
Tyrode   Tyrode group 
Tyrode + Orci  Tyrode group with orciprenaline 
CM   incubated group 
CM + Orci  incubated group with orciprenaline 
CM + LPS  with LPS incubated group 
CM + LPS + Orci with LPS incubated group with orciprenaline 
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7.2 Resting Sarcomere Length 
 
HZ Tyrode + Orci Tyrode CM 
 
Mean SD N Mean SD N Mean SD N 
0.5 1.837696 0.04175956 46 1.8544 0.04270906 45 1.826435 0.04109283 23 
1 1.840273 0.0400792 44 1.858174 0.03643765 46 1.82555 0.04084051 20 
2 1.836913 0.04007483 46 1.848191 0.03961809 47 1.823635 0.04273981 23 
4 1.835163 0.03883845 43 1.84915 0.03561946 40 1.820709 0.04715719 22 
6 1.827537 0.0390289 41 1.839 0.04274843 43 1.818455 0.05187597 22 
8 1.829571 0.03882678 42 1.83931 0.03687255 42 1.821039 0.04634041 26 
10 1.82225 0.0397426 40 1.836774 0.04330028 31 1.81044 0.04199472 25 
 
HZ CM + Orci CM + LPS + Orci CM + LPS 
 Mean SD N Mean SD N Mean SD N 
0.5 1.77825 0.04850626 22 1.76725 0.0498202 24 1.791778 0.04123874 18 
1 1.782349 0.04296523 16 1.776654 0.06135663 26 1.790333 0.03447089 12 
2 1.776902 0.03255201 17 1.777182 0.04396326 22 1.792867 0.04470247 15 
4 1.779823 0.050023 19 1.777727 0.04382654 22 1.805143 0.04996746 14 
6 1.762039 0.042319 15 1.77081 0.03315031 21 1.796818 0.07076414 11 
8 1.770139 0.032378 18 1.770875 0.03394584 24 1.792692 0.05278634 13 
10 1.760283 0.068239 21 1.767789 0.05526491 19 1.781533 0.03378856 15 
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7.3 Shortening Amplitude 
 
HZ Tyrode + Orci Tyrode CM 
 
Mean SD N Mean SD N Mean SD N 
0.5 0.1523617 0.03896736 47 0.1091111 0.04324677 45 0.06421739 0.04709575 23 
1 0.1242222 0.04525391 45 0.07491304 0.02783269 46 0.0448125 0.0343981 16 
2 0.1113617 0.04133116 47 0.0606383 0.02407274 47 0.04952941 0.04421979 17 
4 0.1187045 0.04936272 44 0.0707 0.03482204 40 0.05205263 0.04223805 19 
6 0.1637317 0.06575828 42 0.1157674 0.05664671 43 0.07026667 0.04178069 15 
8 0.1787381 0.02283997 43 0.1128974 0.04402977 39 0.083 0.04432572 14 
10 0.166625 0.03309687 41 0.1095667 0.04755373 30 0.07157143 0.04289356 21 
 
HZ CM + Orci CM + LPS + Orci CM + LPS 
 Mean SD N Mean SD N Mean SD N 
0.5 0.1211304 0.04817327 23 0.12448 0.04904129 25 0.0598 0.04882795 20 
1 0.10455 0.04114988 20 0.1150769 0.0579363 26 0.04461538 0.02899293 13 
2 0.09869565 0.04653878 23 0.0945 0.03228564 22 0.03473333 0.02781178 15 
4 0.109 0.0437286 22 0.08340909 0.04000249 22 0.03942857 0.02156106 14 
6 0.1466818 0.07148452 22 0.119619 0.03687202 21 0.03981818 0.03678703 11 
8 0.1444615 0.03462397 26 0.1295 0.09776636 24 0.0458125 0.06124946 16 
10 0.13296 0.04938047 25 0.1092 0.04405064 20 0.06564286 0.0346246 15 
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7.4 Shortening Speed 
 
HZ Tyrode + Orci Tyrode CM 
 
Mean SD N Mean SD N Mean SD N 
0.5 7.605298 3.038752 47 5.794533 2.677847 45 4.468136 2.277331 22 
1 6.7098 2.908099 45 4.522109 2.188971 46 3.43025 1.791918 16 
2 6.564511 2.988965 47 3.895319 1.388623 47 3.141471 2.806596 17 
4 7.570273 3.008582 44 4.122225 1.895514 40 3.080158 2.416993 19 
6 7.84381 3.286478 42 4.743046 2.365062 43 3.679 2.688332 15 
8 7.860465 3.568208 43 4.582857 2.316087 42 3.699375 1.554957 16 
10 7.240415 3.491793 41 4.412871 2.314439 31 3.543667 1.652339 21 
 
HZ CM + Orci CM + LPS + Orci CM + LPS 
 Mean SD N Mean SD N Mean SD N 
0.5 7.136435 2.880142 23 5.94588 3.209838 25 2.58145 2.443199 20 
1 6.2256 2.754199 20 5.379231 2.58942 26 2.353 1.220107 13 
2 5.544391 2.500017 23 4.804636 2.375489 22 2.3094 1.35034 15 
4 6.4395 2.592926 22 5.013091 2.011922 22 2.259072 1.335056 14 
6 6.938727 2.103701 22 5.330857 2.766795 21 2.370417 1.232327 12 
8 6.752269 2.21494 26 5.286708 2.25204 24 2.5014 1.834629 15 
10 6.2604 2.584746 2 4.94065 1.90705 20 2.379357 1.205238 15 
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7.5 Relaxation Speed 
 
HZ Tyrode + Orci Tyrode CM 
 
Mean SD N Mean SD N Mean SD N 
0.5 5.80517 2.957723 47 3.884822 2.162217 45 2.516 1.262093 20 
1 4.826622 2.573603 45 2.72337 1.671507 46 1.789 1.397317 16 
2 4.528979 2.581084 47 2.024542 1.202826 48 1.670812 1.440541 16 
4 5.236591 2.603436 44 2.5171 1.538392 40 2.004684 1.932093 19 
6 5.620572 2.811966 42 3.275837 2.028436 43 2.1864 2.453117 15 
8 5.850395 2.993081 43 3.117 1.949845 42 1.905333 1.684684 18 
10 5.359366 2.930547 41 3.009452 1.84792 31 1.891571 1.456189 21 
 
HZ CM + Orci CM + LPS + Orci CM + LPS 
 Mean SD N Mean SD N Mean SD N 
0.5 5.405826 2.967989 23 4.51236 3.137887 25 2.136 2.123577 20 
1 4.89785 2.595334 20 3.970923 2.824979 26 1.337923 0.9088844 13 
2 4.811565 2.815322 23 3.637136 2.797671 22 1.078133 0.8161232 15 
4 5.265954 2.703801 22 3.649409 3.061155 22 1.375929 0.9373624 14 
6 6.040773 3.671307 22 3.991333 2.923011 21 1.406455 0.8109108 11 
8 5.783154 3.537346 26 3.864875 3.117442 24 1.798625 1.567051 16 
10 5.11532 3.129091 25 3.6113 2.574592 20 1.556571 0.8885186 15 
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